Cancer

News

Sanofi to acquire Kiadis and NK cell tech for $353 million

Sanofi is to acquire Kiadis, a biotech specialising in therapies based around ‘off the shelf’ natural killer (NK) cells, for 308 million euros ($353 million).

News

ANGLE raises £20m, eyes opportunity in immunotherapy trials

Liquid biopsy company ANGLE has raised £20m through a conditional placing on the London Stock Exchange which will be used to expand commercial opportunities.

News

DNA strand and Cancer Cell Oncology Research Concept 3D rendering

Exact Sciences buys cancer detection company Thrive for $2.1...

Stocks for Exact Sciences leaped 33% after it announced the acquisition of liquid biopsy rival Thrive and UK start-up Base Genomics.

Views & Analysis

Toxic positivity and grief: The reality of living through ca...

Cancer doesn’t end when treatment stops – it’s a lifelong journey and people need support throughout, says patient advocate Megan-Claire Chase.

News

FDA grants fast review for AstraZeneca's Tagrisso in early-s...

The FDA has granted a fast review for AstraZeneca’s Tagrisso oncology drug in certain patients with early-stage lung cancer.

News

COVID-19 tests prop up Roche as US biosimilars bite in Q3

Roche’s pharmaceutical revenues have been hit by falling sales in its pharma division in Q3 but a spike in demand for COVID-19 tests spared the Swiss company's blushes.

Sanofi to acquire Kiadis and NK cell tech for $353 million

ANGLE raises £20m, eyes opportunity in immunotherapy trials

Exact Sciences buys cancer detection company Thrive for $2.1...

Toxic positivity and grief: The reality of living through ca...

FDA grants fast review for AstraZeneca's Tagrisso in early-s...

COVID-19 tests prop up Roche as US biosimilars bite in Q3

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

Cancer

Editor's Picks